# OnCo record nct04919811 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04919811/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04919811", "NCT04919811" ;
  schema:name "Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC"@en ;
  schema:alternateName "TRUST-II"@en ;
  schema:description "A phase 2 trial of Taletrectinib in non-small-cell lung cancer and small-cell lung cancer, run by Nuvation Bio Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04919811/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04919811> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2021-09-01" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/ros1-positive-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/taletrectinib/> ;
  onco:companies <https://onco.cc/companies/nuvation-bio/> .